Immune system changes linked to inflammatory bowel disease revealed
2010-12-10
(Press-News.org) Scientists at the Virginia Bioinformatics Institute at Virginia Tech have discovered some of the key molecular events in the immune system that contribute to inflammatory bowel disease. The results, which help researchers move one step further in their efforts to develop new drugs to treat inflammatory and immune-mediated diseases, are reported in the November 2010 edition (http://www.ncbi.nlm.nih.gov/pubmed/21068720) of the journal Mucosal Immunology from the Nature Publishing Group.
Inflammatory bowel disease starts when the gut initiates an abnormal immune response to some of the one hundred trillion or so bacteria that come into contact with the colon of the human body.
More than 1 million people are affected by inflammatory bowel disease in North America alone and direct healthcare expenses for inflammatory bowel disease in the United States are estimated at more than $15 billion annually.
Earlier mathematical and computational work (http://www.ncbi.nlm.nih.gov/pubmed/20362587) by the scientists pinpointed a special type of immune cell as a possible target for intervention strategies to fight inflammation-related disease in the gut. The immune cells identified in the earlier work, which are known as M1 or classically activated macrophages, cause inflammation and possess a specific molecule, peroxisome proliferator-activated receptor-gamma, that, when activated, favors a switch to a type of macrophage that reduces the impact of inflammation (alternatively activated macrophage or M2) . The activation of the receptor protein and the anti-inflammatory M2 macrophage switch plays a beneficial role in reducing the severity of the disease in the gut during experimentally induced inflammatory bowel disease.
"We have been able to validate experimentally some of the key events that take place in the regulation of the mucosal immune system when inflammatory bowel disease is triggered in mice," said Josep Bassaganya-Riera, associate professor of immunology at the Virginia Bioinformatics Institute, leader of the Nutritional Immunology and Molecular Medicine Group in the institute's CyberInfrastructure Division, and principal investigator. "When we produce mice that lack the peroxisome proliferator-activated receptor-gamma specifically found in macrophages, the severity of inflammatory bowel disease increases significantly. In parallel, we are able to observe the impact of the onset of disease on key inflammation-related genes and other molecules involved in inflammation and metabolism."
"In this study, we were able to use mouse Affymetrix GeneChips® to examine which genes were turned on and off under disease and non-disease conditions," said Clive Evans, director of the Core Laboratory Facility at the institute. "This gave us a comprehensive snap-shot of what is happening in the immune system of mice when inflammation-related disease takes hold in the gut."
"In addition to our observations of what is happening when inflammatory bowel disease is triggered in mice, we showed that peroxisome proliferator-activated receptor-gamma in macrophages is essential for recovery from disease when the drug pioglitazone is used to treat it," said Raquel Hontecillas, assistant professor of immunology at the Virginia Bioinformatics Institute, and lead investigator of the study. "Our group has dissected the role of peroxisome proliferator-activated receptor-gamma as an internal thermostat for inflammation in other cells involved in gut inflammation such as intestinal epithelial cells and T cells."
Some of the currently available therapies for the treatment of inflammatory bowel disease in humans are effective in treating the disease but are linked to sometimes-drastic side effects in patients. The researchers hope to use their knowledge of the immune system and specific targets for repurposed drugs and naturally occurring compounds to develop safer alternatives for the long-term management of the disease.
"Our combined computer modeling and experimental validation approach, which is part of the work of our Center for Modeling Immunity to Enteric Pathogens, is already generating important clinical leads that should help us in our quest to deliver better therapies for infectious enteric diseases," concluded Bassaganya-Riera.
INFORMATION:
The research was funded by award number 5R01AT004308 of the National Center for Complementary and Alternative Medicine at the National Institutes of Health, European Commission grant number 224836, the Virginia Bioinformatics Institute-Fralin Commonwealth Research Initiative grants program, National Institute of Allergy and Infectious Diseases Contracts No. HHSN272200900040C and HHSN272201000056C, and funds from the Nutritional Immunology and Molecular Medicine Laboratory.
About the Nutritional Immunology and Molecular Medicine Group
The Nutritional Immunology and Molecular Medicine Group conducts translational research aimed at developing novel therapeutic and prophylactic approaches for modulating immune and inflammatory responses. The group combines computational modeling, bioinformatics approaches, pre-clinical experimentation and human clinical studies to better understand the mechanisms of immune regulation at mucosal surfaces and ultimately accelerate the development of novel treatments for infectious and immune-mediated diseases. Learn more at: www.vbi.vt.edu/nimm
Learn more about Josep Bassaganya-Riera at https://www.vbi.vt.edu/vbi_faculty/vbi_persons/dev_vbi_faculty?personId=177
Related links
VBI awarded $10.6 million from NIH to model immune responses to gut pathogens
http://www.vtnews.vt.edu/articles/2010/10/101410-vbi-immunity.html
Math model of colon inflammation singles out dangerous immune cells
http://www.vtnews.vt.edu/articles/2010/08/081110-vbi-mathmodel.html
END
ELSE PRESS RELEASES FROM THIS DATE:
2010-12-10
Researchers at the Virginia Bioinformatics Institute at Virginia Tech have discovered how abscisic acid, a natural plant hormone with known beneficial properties for the treatment of disease, helps fight inflammation. The results (http://www.ncbi.nlm.nih.gov/pubmed/210882970), which are published in the November 2010 Journal of Biological Chemistry, reveal important new drug targets for the development of treatments for inflammatory and immune-mediated diseases.
The scientists had reported some of the key molecular events in the immune system of mice that contribute to ...
2010-12-10
ALBUQUERQUE, N.M. — A benchtop version of the world's smallest battery — its anode a single nanowire one seven-thousandth the thickness of a human hair —has been created by a team led by Sandia National Laboratories researcher Jianyu Huang.
To better study the anode's characteristics, the tiny rechargeable, lithium-based battery was formed inside a transmission electron microscope (TEM) at the Center for Integrated Nanotechnologies (CINT), a Department of Energy research facility jointly operated by Sandia and Los Alamos national laboratories.
Says Huang of the work, ...
2010-12-10
DURHAM, N.C. – Using lasers to contain some ultra-chilled atoms, a team of scientists has measured the viscosity or stickiness of a gas often considered to be the sixth state of matter. The measurements verify that this gas can be used as a "scale model" of exotic matter, such as super-high temperature superconductors, the nuclear matter of neutron stars, and even the state of matter created microseconds after the Big Bang.
The results may also allow experimental tests of string theory in the future.
Duke physicist John Thomas made the viscosity measurements using an ...
2010-12-10
Despite a 30-year warming trend, the last three years in the Bering Sea have been the coldest on record. A University of Alaska Fairbanks scientist says that the cold temperatures have helped produce larger zooplankton in the Bering Sea, which may affect the way Walleye pollock feed.
Alexei Pinchuk, research professional at the UAF Seward Marine Center, has spent the last three years gathering zooplankton samples in the Bering Sea. He and his colleagues have been looking at how changes in temperature in the Bering Sea affect resident zooplankton and, in turn, how those ...
2010-12-10
New research suggests that private industry and academic science pursue different goals with different consequences, but that the two can still be complementary.
Over the past three decades, private funding and collaboration in university-based research has risen steadily. That has led to concerns about the independence and integrity of public science. However, University of Chicago sociologist James Evans finds that industry can advance academic science by shaking up its conservative nature and encouraging novel discovery.
Evans's research, released today in the American ...
2010-12-10
OAK RIDGE, Tenn., Dec. 9, 2010 -- A quicker and cheaper technique to scan molecular databases developed at the Department of Energy's Oak Ridge National Laboratory could put scientists on the fast track to developing new drug treatments.
A team led by Jerome Baudry of the University of Tennessee-ORNL Center for Molecular Biophysics adapted a widely used existing software to allow supercomputers such as ORNL's Jaguar to sift through immense molecular databases and pinpoint chemical compounds as potential drug candidates.
The research was published in the Journal of ...
2010-12-10
Used in the proper amounts, it can make teeth stronger and aid in the treatment of osteoporosis. When excessive amounts are consumed, however, it can be a killer — a carcinogen that causes bone, lung and bladder cancers. The "it" is fluoride, a common additive in most American communities' drinking water and an ingredient in the vast majority of commercially produced adult toothpastes.
Determining the level of fluoride, be it in water, consumer products or the human body, is an important and attractive challenge for scientists. To address that, a Florida State University ...
2010-12-10
A collaborative, government-led effort to guide and standardize diagnosis, treatment and management of food allergies has resulted in the release of an official set of recommendations for physicians.
The guidelines are being published online this week by the Journal of Allergy and Clinical Immunology (JACI), and available online at www.niaid.nih.gov/topics/foodallergy/clinical/Pages/default.aspx. They were developed by the National Institutes of Health and leading researchers and clinicians, professional and patient advocacy organizations, and the American Academy of ...
2010-12-10
Shootings like the one in which a gunman shot a doctor and killed a patient at The Johns Hopkins Hospital in September are "exceedingly rare," but the rate of other assaults on workers in U.S. health care settings is four times higher than other workplaces, conclude two Johns Hopkins emergency physicians after reviewing workplace violence in health settings.
The rate of assault in all private-sector industries in the United States is two per 10,000, compared to eight per 10,000 at health care workplaces, note Gabor D. Kelen, M.D., and Christina L. Catlett, M.D., in a ...
2010-12-10
Using buprenorphine instead of methadone — the current standard of care — to treat opioid-dependent pregnant women may result in healthier babies, suggests new findings from an international team led by Johns Hopkins researchers and published in the Dec. 9 issue of the New England Journal of Medicine.
Babies born to mothers taking buprenorphine instead of methadone to counter heroin and/or prescription opioid addiction were likely to need less morphine to deal with drug withdrawal symptoms, spent half as much time in the hospital after delivery and recovered from neonatal ...
LAST 30 PRESS RELEASES:
[Press-News.org] Immune system changes linked to inflammatory bowel disease revealed
